The abstract is read at the publisher; the summary is JClub's.
Curvature-based ordering of equal-mean dosing schedules is preserved in heterogeneous tumors, even as treatment selection shifts surviving cells toward drug resistance.
- Why it matters: Identical total doses can favor different schedules depending on how exposure is timed, but it was unclear whether heterogeneous sensitivities and selection could flip that curvature-predicted preference.
- What they did: The authors build a mathematical framework where phenotypes share one concentration-effect function and differ only by fixed nonnegative sensitivity scales, then prove schedule ordering depends only on the scalar cumulative treatment effect.
- The result: Baseline heterogeneity and treatment-induced selection can change response magnitude and surviving-cell composition, but cannot reverse the curvature-predicted ordering across different temporal profiles and repeated treatment cycles.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.